Back to search
FDAFDA · Food and drugs·Recall number Z-1289-2013

Helistat Absorbable Hemostatic,Collagen Based Helistat is indicated in surgical procedures (other than ophthalmological and urological surgery) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

Published May 22, 2013 · Recall initiated: March 28, 2013

Summary

FDA records medical device Class II recall Z-1289-2013, published May 22, 2013 and initiated March 28, 2013. Recalling firm: Integra LifeSciences Corporation; Status: Terminated; Reported quantity: 24,342 boxes; Lot: 1104789 1104790, 1110793 1112248, 1110248 1111867. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Integra LifeSciences Corporation
Distributor
Worldwide distribution: USA (nationwide) including Puerto Rico and countries of: Arab Emirates, Argentina, Belgium, Brasil, Canada, Chile, China, Costa Rica, Denmark, Egypt, Spain, France, Great Britain, Italy, Japan, Peru, Singapore, Thailand, and South Africa.
Lot
1104789 1104790, 1110793 1112248, 1110248 1111867
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Helistat Absorbable Hemostatic,Collagen Based Helistat is indicated in surgical procedures (other than ophthalmological and urological surgery) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical. recalled?

Yes. FDA published recall Z-1289-2013 on May 22, 2013. Reported hazard: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.

What should I do if I have this product?

Voluntary: Firm initiated · Letter